Use of the Polo-like kinase 4 (PLK4) inhibitor centrinone to investigate intracellular signalling networks using SILAC-based phosphoproteomics

18Citations
Citations of this article
36Readers
Mendeley users who have this article in their library.

Abstract

Polo-like kinase 4 (PLK4) is the master regulator of centriole duplication in metazoan organisms. Catalytic activity and protein turnover of PLK4 are tightly coupled in human cells, since changes in PLK4 concentration and catalysis have profound effects on centriole duplication and supernumerary centrosomes, which are associated with aneuploidy and cancer. Recently, PLK4 has been targeted with a variety of small molecule kinase inhibitors exemplified by centrinone, which rapidly induces inhibitory effects on PLK4 and leads to on-target centrosome depletion. Despite this, relatively few PLK4 substrates have been identified unequivocally in human cells, and PLK4 signalling outside centriolar networks remains poorly characterised. We report an unbiased mass spectrometry (MS)based quantitative analysis of cellular protein phosphorylation in stable PLK4-expressing U2OS human cells exposed to centrinone. PLK4 phosphorylation was itself sensitive to brief exposure to the compound, resulting in PLK4 stabilisation. Analysing asynchronous cell populations, we report hundreds of centrinone-regulated cellular phosphoproteins, including centrosomal and cell cycle proteins and a variety of likely 'non-canonical' substrates. Surprisingly, sequence interrogation of ∼300 significantly down-regulated phosphoproteins reveals an extensive network of centrinone-sensitive [Ser/Thr]Pro phosphorylation sequence motifs, which based on our analysis might be either direct or indirect targets of PLK4. In addition, we confirm that NMYC and PTPN12 are PLK4 substrates, both in vitro and in human cells. Our findings suggest that PLK4 catalytic output directly controls the phosphorylation of a diverse set of cellular proteins, including Pro-directed targets that are likely to be important in PLK4-mediated cell signalling.

References Powered by Scopus

Basic local alignment search tool

78874Citations
N/AReaders
Get full text

MUSCLE: Multiple sequence alignment with high accuracy and high throughput

35698Citations
N/AReaders
Get full text

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

28704Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Centrosome organization and functions

31Citations
N/AReaders
Get full text

Profiling the Human Phosphoproteome to Estimate the True Extent of Protein Phosphorylation

21Citations
N/AReaders
Get full text

Modelling the functions of polo-like kinases in mice and their applications as cancer targets with a special focus on ovarian cancer

13Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Byrne, D. P., Clarke, C. J., Brownridge, P. J., Kalyuzhnyy, A., Perkins, S., Campbell, A., … Eyers, C. E. (2020). Use of the Polo-like kinase 4 (PLK4) inhibitor centrinone to investigate intracellular signalling networks using SILAC-based phosphoproteomics. Biochemical Journal, 477(13), 2451–2475. https://doi.org/10.1042/BCJ20200309

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 9

50%

Researcher 7

39%

Professor / Associate Prof. 1

6%

Lecturer / Post doc 1

6%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 16

67%

Agricultural and Biological Sciences 5

21%

Medicine and Dentistry 2

8%

Computer Science 1

4%

Save time finding and organizing research with Mendeley

Sign up for free